Quality of life after kidney and pancreas transplantation: a review

Joseph, John; Baines, Lyndsay S.; Morris, Michael; Jindal, Rahul M.

doi:10.1016/s0272-6386(03)00740-6

Cited by 70 publications

(45 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…utilization, return to work in adults, and cognitive development and growth in children, successful kidney transplantation is the superior treatment modality for end-stage kidney disease (33)(34)(35)(36)(37)(38)(39).…”

Section: Discussionmentioning

confidence: 99%

Cost-Related Immunosuppressive Medication Nonadherence Among Kidney Transplant Recipients

Evans¹,

Applegate²,

Briscoe

et al. 2010

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Cost-Related Immunosuppressive Medication Nonadherence Among Kidney Transplant Recipients

Evans¹,

Applegate²,

Briscoe

et al. 2010

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

“…Another step would be to create liaison between the recipient and donor hospitals so that modern surgical and medical practices can be implemented. There should also be improved emotional and psychological support to both the recipient and the donor [54, 55]. However, establishment of a database, may perhaps lead to an erroneous impression the academic community is condoning this practice.…”

Section: Discussionmentioning

confidence: 99%

Commercialization of Kidney Transplants: A Systematic Review of Outcomes in Recipients and Donors

Sajjad

Baines²,

Patel³

et al. 2008

Am J Nephrol

View full text Add to dashboard Cite

In this study we systematically reviewed outcomes in recipients and donors of commercial kidney transplants. Inherent in a study of this nature is the possibility of center and country bias, in particular there are no publications from China and South America. Publications also tended to report poor outcomes which may reflect bias on the part of the authors or to highlight the ethical issues in this area. We were unable to perform a meta-analysis due to variability in studies making it impossible to synthesize the data other than descriptive. Furthermore, these studies were not large or well conducted. We found that patient and graft survival was generally inferior to the data obtained from the UNOS (United Network for Organ Sharing). Some studies did achieve good outcomes, however, due to lack of details, it was not possible to infer if the donor hospital, surgical technique or immunosuppressive regimen was a factor. There was a higher incidence of unconventional and life-threatening infections such as malaria, invasive fungal infections, pneumonia, HIV and hepatitis. There was also a markedly increased incidence of postoperative surgical interventions in recipients. We suggest the establishment of a database for both recipients and donors to identify unique surgical, medical, infectious and immunosuppressive protocols for the recipients and donors in these hospitals. This could lead to better liaison between the recipient and donor hospitals so that modern surgical and medical practices can be implemented. There should also be improved emotional and psychological support to both the recipient and the donor. However, these steps could be seen as condoning the reprehensible practice of commercialization of human body parts.

show abstract

“…Kidney transplantation is the renal replacement therapy of choice for most patients. Compared to dialysis treatment, transplantation substantially prolongs survival, improves quality of life, and offers a lower cost-effectiveness ratio [3][4][5][6][7][8].…”

Section: Introductionmentioning

confidence: 99%

Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach

2009

View full text Add to dashboard Cite

show abstract

Quality of life after kidney and pancreas transplantation: a review

Cited by 70 publications

References 68 publications

Cost-Related Immunosuppressive Medication Nonadherence Among Kidney Transplant Recipients

Cost-Related Immunosuppressive Medication Nonadherence Among Kidney Transplant Recipients

Commercialization of Kidney Transplants: A Systematic Review of Outcomes in Recipients and Donors

Cost-effectiveness of immunosuppressive regimens in renal transplant recipients in Germany: a model approach

Contact Info

Product

Resources

About